Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: Trxade Health’s net loss narrows in Q1 2023; revenue down 31%
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the first quarter of fiscal 2023. The company’s net loss narrowed from the prior-year quarter.
Revenues decreased 31% from last year to $2.2 million in the first three months of the fiscal year. The decline mainly reflects weak performance by the Trxade Prime subsidiary.
Net loss attributable to Trxade Health was $677,953 or $0.07 per share in Q1, compared to a loss of $960,147 or $0.12 per share in the same period of last year.
“We continue to focus the Company’s strategic plans and partnerships, working towards creating sustainable value for our stockholders. I am pleased with the growth we have experienced in our TRxADE platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.
Trxade’s stock has gained about 32% since the beginning of the year. The shares closed Monday’s regular trading session higher.
Prior Performance
Most Popular
ORCL Infographic: Oracle Q3 profit rises on higher revenues
Technology giant Oracle Corporation (NYSE: ORCL) Monday reported higher revenues and adjusted earnings for the third quarter of 2025. Total revenues increased to $14.13 billion in the February quarter from
eBay (EBAY): Here are a few strategic initiatives anticipated to fuel growth
Shares of eBay Inc. (NASDAQ: EBAY) fell over 4% on Monday. The stock has gained 8% year-to-date. The company delivered revenue and profit growth for the fourth quarter of 2024
After mixed Q2, can Costco navigate consumer caution and tariff woes?
Costco Wholesale Corporation’s (NASDAQ: COST) second-quarter report failed to impress the market as earnings missed estimates amid cautious consumer spending. The mixed results have come at a time when retailers,
